A patient is prescribed inamrinone (Inocor) by continuous intravenous infusion. When you make rounds and assess the patient, the intravenous bag infusing is labeled (Primacor). What should you do?
a. Stop the infusion and notify the prescriber.
b. Assess the infusion site for a blood return.
c. Document the infusion and site conditions as the only action.
d. Slow the infusion rate because Primacor is more potent than Inocor.
ANS: A
You might also like to view...
Heat applications are often used to promote tissue healing. What is the rationale for this type of treatment?
A) Physiologic effects of heat accelerate the inflammatory response. B) Local heat increases cardiac output and pulse rate. C) Heat reduces blood flow to tissues resulting in decreased edema. D) Heat reduces muscle tension to promote relaxation.
The nurse is planning interventions to promote the health of a family struggling with loss of energy and privacy for the parents. In which family stage is the family?
A) Family with young children B) Family with adolescents and young adults C) Family with middle-aged adults D) Family with older adults
Ordered: potassium chloride (KCl) IV 0.5 mEq per hr, for a baby with hypokalemia Pediatric SDR: up to 3 mEq per kg per 24 hr Child's weight: 16 lb Available: 10 mEq KCl in 100 mL D5W a. Child's weight in kilograms to the nearest tenth: b. SDR for this child: c. Decision: safe or unsafe order? State the reason.If safe to give, what flow rate should the nurse set on an infusion pump?
d. DA equation: e. Evaluation: f. The IV is to be infused with a volume-control device. Agency policy states that only a 2-hour supply may be placed in the device. How many milliliters should the nurse place in the chamber?
In a patient admitted with cellulitis of the left foot, which of the following clinical manifestations would you expect to find on assessment of the left foot?
A. Redness and swelling B. Pallor and poor turgor C. Cyanosis and coolness D. Edema and brown skin discoloration